# KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/kras-mutation-as-a-prognostic-factor-and-predictive-factor-in-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Rebecca Goulding,Matthew Chenoweth,Gebra Cuyún Carter,Mark E. Boye,Kristin M. Sheffield,William J. John,Mark S. Leusch,Catherine E. Muehlenbein,Li Li,Min‐Hua Jen,Adina Rojubally,Jeroen J. Jansen,Eric Druyts |
| Citations | 63 |
| DOI | 10.1016/j.ctarc.2020.100200 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.sciencedirect.com/science/article/pii/S246829422030037X/pdf |
| OpenAlex ID | https://openalex.org/W3045278119 |
| PMID | 32750661 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Adina Rojubally](https://scholariq.org/researchers/adina-rojubally/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.